InvestorsHub Logo
Followers 28
Posts 4372
Boards Moderated 1
Alias Born 09/22/2006

Re: biotechinvestor1 post# 7259

Wednesday, 11/23/2022 8:31:39 AM

Wednesday, November 23, 2022 8:31:39 AM

Post# of 8686
Thanks. HALO PR department has some updating to do on their parter pipeline chart, both for
Nivolumab + Relatlimab (phase 1 to phase 3) and for Efgartigimod (now filed)
https://halozyme.com/enhanze/#pipeline_group_1

The more you know, the less you don't know.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News